Hepatic farnesoid X receptor protein level and circulating fibroblast growth factor 19 concentration in children with NAFLD

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|38|2|342-349

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.38, Iss.2, 2018-02, pp. : 342-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic elevation of plasma fibroblast growth factor 19 in long‐term farnesoid X receptor agonist therapy, a happy marriage or cause for oncological concern?

By  

HEPATOLOGY, Vol. 67, Iss. 2, 2018-02 ,pp. : 782-784

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genomic analysis of hepatic farnesoid X receptor binding sites reveals altered binding in obesity and direct gene repression by farnesoid X receptor in mice

By  

HEPATOLOGY, Vol. 56, Iss. 1, 2012-07 ,pp. : 108-117

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of the fibroblast growth factor receptor axis in cholangiocarcinoma

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 7, 2015-07 ,pp. : 1116-1122

John Wiley & Sons Inc

Access to resources Recommend Favorite

Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 4, 2015-04 ,pp. : 1133-1144

John Wiley & Sons Inc

Access to resources Recommend Favorite

Commentary: fibroblast growth factor 19 in patients with bile acid diarrhoea

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 10, 2013-11 ,pp. : 1320-1321

John Wiley & Sons Inc

Access to resources Recommend Favorite